Interview
Video

Beyond the Data: New in ACS From ESC 2022

September 6, 2022

18:59

Mamas Mamas and Alaide Chieffo discuss the perils of single-sex trials, MINOCA unknowns, low EF after AMI revascularization, and more.

Alaide Chieffo
ACS
Interview

Recommended Videos

University of Washington Medical Center, Seattle, WA - Balloon Expandable TMVR in Severe MAC sp SEASAME Procedure 42:51

University of Washington Medical Center, Seattle, WA - Balloon Expandable TMVR in Severe MAC sp SEASAME Procedure

Honor Health Medical Center, Scottsdale, AZ - Mitral TEER in Secondary MR 42:40

Honor Health Medical Center, Scottsdale, AZ - Mitral TEER in Secondary MR

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial) 47:20

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial)

University Hospital of Cologne, Department of Cardiology, Cologne, Germany - A Novel Transcatheter Tricuspid Valve Replacement for TR 43:41

University Hospital of Cologne, Department of Cardiology, Cologne, Germany - A Novel Transcatheter Tricuspid Valve Replacement for TR

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR 46:02

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR

Scripps ClinicScripps Memorial Hospital La Jolla, CA - Complex PCI – Calcified Coronary Treatment 42:48

Scripps ClinicScripps Memorial Hospital La Jolla, CA - Complex PCI – Calcified Coronary Treatment

Saint Luke’s Mid America Heart Institute, Kansas City, MO - Complex Coronary PCI (MVD) and Ischemic Cardiomyopathy 46:00

Saint Luke’s Mid America Heart Institute, Kansas City, MO - Complex Coronary PCI (MVD) and Ischemic Cardiomyopathy

AHA 2023 Wrap-Up 08:45

AHA 2023 Wrap-Up

Lead Management in Patients with Tricuspid Regurgitation and CIEDs 21:27

Lead Management in Patients with Tricuspid Regurgitation and CIEDs

Antiplatelet Decision Making in High-Risk PCI 00:43

Antiplatelet Decision Making in High-Risk PCI

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve 12:49

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

Beyond the Data: ORBITA-2 16:33

Beyond the Data: ORBITA-2

Beyond the Data: DAPA-MI 21:07

Beyond the Data: DAPA-MI

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis 05:36

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study 03:12

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial 42:51

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial

Interview

See All (366)
Beyond the Data: ORBITA-2 16:33
AHA 2023

Beyond the Data: ORBITA-2

Beyond the Data: DAPA-MI 21:07
AHA 2023

Beyond the Data: DAPA-MI

Beyond the Data: The T-PASS Trial 12:05
TCT 2023

Beyond the Data: The T-PASS Trial

On Record: Out With ABIM, In With a CV Board 10:43
TCT 2023

On Record: Out With ABIM, In With a CV Board

Beyond the Data: Tricuspid Valve Interventions 09:36
TCT 2023

Beyond the Data: Tricuspid Valve Interventions

Beyond the Data: The WATCH-TAVR Trial 14:57
TCT 2023

Beyond the Data: The WATCH-TAVR Trial

Beyond the Data: Aortic Stenosis in the Frail Patient 10:35

Beyond the Data: Aortic Stenosis in the Frail Patient

Beyond the Data: Removing Barriers in Structural Heart Care 10:18
TCT 2023

Beyond the Data: Removing Barriers in Structural Heart Care